Aortic Stent grafts have emerged as the most viable option for treating aortic and thoracic aneurysms in elective and emergent situations. Aortic aneurysms can be treated either through open or EVAR surgical techniques. An aging population, increased screening programs, and the shift from open repair surgerytechnique to EVARtechniqueare some of the prominent factors contributing to the increasing growth of aortic stent grafting market. The growing preference for MI procedures such as EVAR and TEVAR among both patients and surgeons is hugely benefitting the market. Further, the increasing frequency of screening programs to make people aware of aortic stent grafts and the launch of new products are going to significantly drive the aortic stent grafting market.

  • EVAR procedures account for around 75% of all repair procedures due to lower mortality rate, fewer complications, and short recovery time.

Increasing Screening Programs for the Detection of Aortic Aneurysm

  • Only 10% of all abdominal aortic aneurysm (AAAs) are being diagnosed.
  •  The Denmark clinical study confirmed a 67% reduction in AAA-specific mortality and an estimated cost per prevented death from aortic aneurysm of around $18,000.
  • In Sweden, the general AAA screening program for people 65 years and above age was introduced in 2006 and reached nationwide coverage in 2015.

The early detection of aortic aneurysm is an effective way to reduce high mortality. The availability of screening programs has gained significance both for the general public and physicians to treat aortic aneurysms with stent grafts. In addition, the introduction of screening programs for aortic aneurysm detection among women is also gaining prominence as the prevalence/incidence of the disease is also increasing in them. For instance, comprehensive modeling has shown that offering screening programs for aortic aneurysm among women, using similar screening protocol like men in the UK, would reduce deaths from AAA in women aged between 65 and 75 years by 7% and 3% in women aged between 65 and 95 years. Thus, the increasing number of government screening programs for elderly people has provided huge growth opportunities for manufacturers in the aortic stent grafting market as these programs directly increasethe target pool of patients requiring repair procedures and aortic stent grafts.

New Product Approvals/Launches

  • In 2019, W.L. Gore & Associates introduced GORE TAG, a conformable thoracic stent graft with active control.
  • Cordis (Cardinal Health) introduced the INCRAFT AAA Stent Graft System in the US.

New product approvals and launches of aortic stent grafts with improved designs are expected to provide enormous growth opportunities to the aortic stent grafting market. The clinical utilization of aortic stent grafts to treat aortic aneurysms has increased significantly over the past few years due to the introduction of innovative devices with the significantoutcome of MI aneurysm repair procedures. Further, vendors are strategically focusing on the development and commercial launch of aortic stent grafts for treating abdominal as well as thoracic aortic aneurysms. They are also actively involved in launching innovative devices to penetrate and tap huge growth opportunities in the aortic stent graftingmarket. Further, new product approvals/launches, coupled with increased R&D activities, are expected to help vendors to expand geographical presence, enhance market growth, and sustain position in the global aortic stent grafting market.

Vendors are also planning to introduce innovative products in the coming years. For instance,Medtronic and W. L. Gore & Associates have increased their market share due to continuous involvement in product innovations and launches. Other key players such as Terumo, MicroPort Scientific, Cardinal Health, and CryoLifehave also received regulatory approvals for their aortic stent grafts. Hence, the effect of new product approvals and launches that took place between late 2015 and 2019 is positively affecting the aortic stent grafting market,thereby contributing the market growth worldwide.

Read: Aortic Stent Graft Market - Global Outlook and Forecast 2019-2024

You may reach us at

enquiry@arizton.com